More than 180 venture capital firms have supported startup companies launched by UC Berkeley entrepreneurs.
This is a partial list of venture capitalists that have invested in startups launched with UC Berkeley intellectual property rights.
THANK YOU FOR YOUR SUPPORT OF BERKELEY ENTREPRENEURS!
- 3i
- 5AM Ventures
- Abingworth Management
- Activate Capital
- Acumen Foundation
- Adams Street Partners
- Advanced Technology Ventures
- Ajax Investment Strategies
- Alexandria Venture Investments
- Allen & Company
- Alta Partners
- AME Cloud Ventures
- Amzak Health
- Apax Partners
- Applied Genomic Technology Capital (AGTC) Funds
- Archangel BioVentures
- Arch Venture Partners
- Ardesta
- Atlas Venture
- Avery Dennison
- Beagle Ltd.
- Berkeley Catalyst Fund
- Bill and Melinda Gates Foundation
- Biomedical Partners
- Biotechnology Value Fund
- BioVeda Capital
- Bow Capital
- Casdin Capital
- Chiesi Ventures Fund
- Claremont Creek Ventures
- Clearvision Ventures
- CMEA Ventures
- Convexa
- Credit Suisse First Boston
- Crocker Capital
- Cross Creek Advisors
- CSFB Private Equity
- DAG Ventures
- Delphi Ventures
- De Novo Ventures
- Deutsche Telekom Strategic Investments
- DFJ - Draper Fisher Jurvetson
- Digital Bandwidth
- Dolby Family Ventures
- Domain Associates
- Dorm Room Fund
- Dow Chemical Company
- Dupont iTechnologies
- EcoR1 Capital
- Engie
- E.M. Warburg, Pincus & Co.
- Emigrant Capital
- Equitek Capital
- Essex Woodlands
- Fidelity Management and Research Company
- Fifty Years
- First Analysis
- Fisk Ventures
- Flagship Pioneering
- Foresite Capital
- Forward Ventures
- Frazier Healthcare Ventures
- Gabriel Venture Partners
- Gemalto
- General Catalyst Partners
- Globespan Capital Partners
- Goldman, Sachs & Co.
- Greenspring Associates
- GV
- Halo Fund
- HBM Bioventures (formerly Roche Holding AG)
- HNW Capital
- Horizons Ventures
- The House Fund
- Humboldt Fund
- Hummer Winblad Venture Partners
- Icon Ventures
- In-Q-Tel
- Intel Capital
- International Biotechnology Trust
- International BM Biomedicine / Global Biomedical Partners
- Impact Science Ventures
- Janus Capital Management
- Jafco Ventures
- JP Morgan
- Juniper Networks
- Khosla Ventures
- Kleiner Perkins Caulfield & Byers
- Kodiak Venture Partners
- Life Science Angels
- Lightspeed Venture Partners
- Lombard Odier & Cie
- Longevity Vision Fund
- Lumira Capital
- Lux Capital
- M12
- Macquarie Capiital
- Material Impact
- Matrix Partners
- Mayfield Fund
- MDS Capital Corp
- Microsoft Climate Innovation Fund
- Mirae Asset Financial Group
- Mission Bay Capital
- Mission BioCapital
- Mohr Davidow Ventures
- Morningside Ventures
- Mubadala Capital
- Mubadala Capital
- Neuberger Berman
- New Enterprise Associates
- New Medical Technologies
- NGEN Partners
- Norwest Venture Partners
- Oak Investment Partners
- Octagon Capital Group
- NGEN Partners
- Norwest Venture Partners
- Noventi
- Oak Investment Partners
- Octagon Capital Group
- OrbiMed Advisors
- Osage University Partners
- Pappas Capital
- Partech Ventures
- Pfizer Ventures
- Philips Electronics
- Phoenix Venture Partners
- Physic Ventures
- Pivotal Ventures
- Plug and Play Ventures
- Polaris Partners
- Prolog Ventures
- Quad Investment Management
- Qualcomm Ventures
- Quan Ventures
- QuestMark Partners
- Qventures
- Red Tree Venture Capital
- Rock Health
- RA Capital Management
- RD Fund
- Rho Management
- Rona Holdings
- RTW Investments
- Samsung Ventures
- Scale Venture Partners
- Sectoral Asset Management
- Sequoia Ventures
- Sevin Rosen Funds
- SG Cowen
- Sierra Ventures
- Skyline Ventures
- StartX
- Strategic Partners
- Streamlined Ventures
- T Venture
- Tallwood Venture Capital
- The Angels' Forum
- The Column Group
- Third Rock Ventures
- Thomas, McNerny & Partners
- Toray International
- TPG Growth
- Tuatara Capital, L.P.
- UPM-Kymmene
- Vantage Point Capital Partners
- Venrock Associates
- Versant Ventures
- Vertex Ventures
- Viking Global Investors
- Vision Ridge Capital
- Vista Equity Partners
- Vista Ventures
- Walden Riverwood Ventures
- Western Technology Investment Inc. (WTI)
- Wilson Sonsini Goodrich & Rosati
- X/Seed Capital Management